Early patient experiences with montelukast orally disintegrating tablets in Japa
Not Applicable
Completed
- Conditions
- Bronchial asthamaAllergic rhinitis
- Registration Number
- JPRN-jRCT1080223208
- Lead Sponsor
- MSD K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
20 years old or older at the time of registration.
Patients taking montelukast sodium OD tablets for asthma or AR treatment at enrollment.
Patients who have taken montelukast sodium OD tablets for 2 weeks or more at enrollment.
Patients who can understand and complete Japanese questionnaires.
Exclusion Criteria
Patients for whom montelukast sodium OD tablets are prescribed for the first time at enrollment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method